Literature DB >> 7614818

Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.

B J Biemond1, M Levi, H Ten Cate, T Van der Poll, H R Büller, C E Hack, J W Ten Cate.   

Abstract

1. Disseminated intravascular coagulation frequently accompanies Gram-negative sepsis and may contribute to widespread deposition of microthrombi. Besides the endotoxin-induced activation of coagulation, an important role for the fibrinolytic system has been postulated. The precise mechanisms underlying these fibrinolytic changes during endotoxaemia are not known but have been suggested to be mediated directly by cytokines or secondary to thrombin generation. 2. In the present study we have delineated in detail the fibrinolytic response to a bolus injection of endotoxin in non-human primates and analysed the contribution of cytokines and thrombin generation to the endotoxin-induced release of tissue-type plasminogen activator and plasminogen activator inhibitor 1. Chimpanzees received a bolus injection of endotoxin alone or in combination with blocking monoclonal antibodies directed against tumour necrosis factor or interleukin 6 or in combination with pentoxifylline. Furthermore, to assess the effect of coagulation activation on the activation of fibrinolysis, another group of chimpanzees received endotoxin in combination with either anti-tissue factor antibodies or recombinant hirudin. 3. Infusion of endotoxin induced a rapid increase in plasminogen activator activity and tissue-type plasminogen activator antigen levels and subsequent plasmin generation, reaching peak levels 2h after endotoxin administration. Plasminogen activator inhibitor 1 levels remained constant for the first 2 h, after which time a steep increase was observed. Plasminogen activator activity and plasmin generation decreased simultaneously with the rise in plasminogen activator inhibitor 1 levels. Fibrinolytic activity remained suppressed during the remainder of the study owing to sustained increased levels of plasminogen activator inhibitor 1. The administration of pentoxifylline strongly attenuated the release of tissue-type plasminogen activator and plasminogen activator inhibitor 1, whereas the antitumour necrosis factor antibodies blocked the fibrinolytic response entirely. In contrast, interleukin 6-neutralizing antibodies did not affect the fibrinolytic response. Although endotoxin-induced generation of thrombin was completely prevented by the administration of tissue factor-neutralizing antibodies or by hirudin, no effect on the fibrinolytic response was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614818     DOI: 10.1042/cs0880587

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  21 in total

1.  Host Pathways of Hemostasis that Regulate Group A Streptococcus pyogenes Pathogenicity.

Authors:  Victoria A Ploplis; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2020       Impact factor: 3.465

2.  Seasonal variations in out of hospital cardiopulmonary arrest.

Authors:  J P Pell; J Sirel; A K Marsden; S M Cobbe
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

3.  Pentoxifylline influences the autocrine function of organ cultured donor corneas and enhances endothelial cell survival.

Authors:  A C Ventura; M Böhnke
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

4.  GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis.

Authors:  Jason E Comer; Cristi L Galindo; Ashok K Chopra; Johnny W Peterson
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Acute coronary thrombosis in a patient with septic shock without any evidence of disseminated intravascular coagulation.

Authors:  Imdad Ahmed; William B Nelson; Timinder S Biring; Chad M House; John Marini; Ranjan Dahiya
Journal:  BMJ Case Rep       Date:  2009-08-20

6.  Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.

Authors:  C Barazzone; D Belin; P F Piguet; J D Vassalli; A P Sappino
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

7.  Expression of coagulation-related protein genes during LPS-induced preterm delivery in the pregnant mouse.

Authors:  Mark Phillippe; Allaire K Diamond; Leigh M Sweet; Karen H Oppenheimer; Diana F Bradley
Journal:  Reprod Sci       Date:  2011-06-21       Impact factor: 3.060

8.  Is D-dimer a predictor of strangulated intestinal hernia?

Authors:  Gokhan Icoz; Ozer Makay; Murat Sozbilen; Baris Gurcu; Cemil Caliskan; Ozgur Firat; Zahide Kurt; Sinan Ersin
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

Review 9.  Sepsis and disseminated intravascular coagulation.

Authors:  Marcel Levi; Evert de Jonge; Tom van der Poll
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

Review 10.  Current drug treatment strategies for disseminated intravascular coagulation.

Authors:  E de Jonge; M Levi; C P Stoutenbeek; S J van Deventer
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.